SCHEMBL4282002

SCHEMBL4282002

Nc1nc(Cl)cc(-c2ccccc2Oc2ccccc2)n1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 10/20 0.69
HSP90AB1 P08238 9/20 0.69
ADCY10 Q96PN6 3/20 0.56
KDM4E B2RXH2 1/20 0.55
MAOB P27338 2/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAOA P21397 1/20 0.42
CDC7 O00311 1/20 0.42
DAPK3 O43293 1/20 0.42
PRKD3 O94806 1/20 0.42
MAP4K4 O95819 1/20 0.42
PAK4 O96013 1/20 0.42
PIM1 P11309 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3718236 0.82 HSP90AA1 (1.00) HSP90AA1HSP90AB1ADCY10KDM4EMAOB
SCHEMBL13880333 0.79 AGPAT2 (0.64) CYP1A2CYP3A4CYP2C19
SCHEMBL3950560 0.76 HSP90AA1 (1.00) HSP90AA1HSP90AB1ADCY10KDM4EKMT2A
SCHEMBL30507528 0.76 HSP90AA1 (0.53) HSP90AA1HSP90AB1KDM4EMAOBNCOA1
SCHEMBL28501185 0.76 HSP90AA1 (0.53) HSP90AA1HSP90AB1KDM4EMAOBNCOA1
SCHEMBL3394031 0.75 NCOA1 (0.44) HSP90AA1HSP90AB1MAOBNCOA1NCOA3
SCHEMBL16441869 0.74 MEN1 (0.75) HSP90AA1HSP90AB1ADCY10KDM4EMEN1
SCHEMBL3952031 0.73 HSP90AA1 (0.78) HSP90AA1HSP90AB1ADCY10KDM4E
SCHEMBL28505487 0.73 ACHE (0.55) HSP90AA1KDM4EMEN1KMT2ANCOA1
SCHEMBL3952089 0.73 HSP90AA1 (0.70) HSP90AA1HSP90AB1ADCY10KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099183-A1 PYRIMIDINES AND USES THEREOF CELL THERAPEUTICS, INC. (US) 2009-04-16 US disclosed
US-7419984-B2 Pyrimidines and uses thereof CELL THERAPEUTICS, INC. (US) 2008-09-02 US disclosed
US-20040204386-A1 Pyrimidines and uses thereof CELL THERAPEUTICS, INC. 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204386-A1 Pyrimidines and uses thereof LPCAT3, LPCAT1, APRT HSP90AA1 4126/4885HSP90AB1 4236/4885ADCY10 1194/4885
US-20090099183-A1 PYRIMIDINES AND USES THEREOF LPCAT3, LPCAT1, APRT HSP90AA1 4006/4885HSP90AB1 3829/4885ADCY10 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.